Pseudorabies virus nanoparticle antigen and preparation method and application thereof
By covalently linking the protective antigen protein of pseudorabies virus to the scaffold protein of nanoparticles, a pseudorabies subunit nanoparticle vaccine was prepared, which solved the problem of insufficient immune protection of existing vaccines against variant strains and achieved efficient and safe immunization and differential diagnostic capabilities.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA ANIMAL HUSBANDRY IND
- Filing Date
- 2025-01-15
- Publication Date
- 2026-07-17
AI Technical Summary
Existing pseudorabies vaccines are not very effective in protecting against viral variants, and it is difficult to distinguish between vaccine-immunized and wild-type virus infection through serological differential diagnosis. Their safety and immunogenicity need to be improved.
The protective antigen proteins gB, gC, and gD of pseudorabies virus were covalently linked in vitro to the nanoparticle backbone protein mi3 to form nanoparticle antigens, and a pseudorabies subunit nanoparticle vaccine was prepared. Combined with ISA 206VG adjuvant, the immune response was enhanced.
It enhances immunogenicity, induces high-level antibody responses, exhibits good safety and persistence, and can differentiate between vaccine-immunized individuals and wild-type virus infections through antibody differential diagnosis, effectively preventing and controlling the spread of pseudorabies.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Citation Information
Patent Citations
Porcine pseudorabies virus gene deleted strain, as well as construction method and application thereof
CN110527669A